| Literature DB >> 30463581 |
Jessica E Bourne1,2, Sarah Sauchelli3, Rachel Perry3, Angie Page4,3, Sam Leary3, Clare England4,3, Ashley R Cooper4,3.
Abstract
BACKGROUND: Electrically assisted bicycles (e-bikes) have been highlighted as a method of active travel that could overcome some of the commonly reported barriers to cycle commuting. The objective of this systematic review was to assess the health benefits associated with e-cycling.Entities:
Keywords: E-bike; Electrically-assisted bicycle; Health; Physical activity
Mesh:
Year: 2018 PMID: 30463581 PMCID: PMC6249962 DOI: 10.1186/s12966-018-0751-8
Source DB: PubMed Journal: Int J Behav Nutr Phys Act ISSN: 1479-5868 Impact factor: 6.457
Fig. 1Flow chart of literature search
Summary of included studies
| First author, year, country | Study design | Participants; gender (%female); | Clinical status | Exposure conditions | Length of intervention | Ride characteristics |
|---|---|---|---|---|---|---|
| Acute studies | ||||||
| Bernsten, 2017, Norway [ | Randomized cross over | Active adults | E-bike vs. CB ( | Trials conducted on same day, 2-min break between trials | Route 1: 8.1 km, flat route | |
| Gojanovic, 2011, Switzerland [ | Non-randomized cross over | Inactive adults | E-bike LA vs. E-bike HA vs. CB vs. walking | Trials conducted over 2-days. 30-min break between trials conducted on same day | Biking: 5.1 km, 178 m elevation gain, average gradient 3.4% Instructed to ride at comfortable pace maintaining 60 rpm | |
| Hansen, 2017, Belgium [ | Randomized cross over | Coronary artery disease | E-bikes LA vs. E-bike HA vs. CB | Trials conducted on separate days (3–4 days between) | 10 km, 102 m elevation change | |
| La Salle, 2017, USA [ | Randomized cross over | Active adults with cycling experience | E-bike pedal assist vs. E-bike NA | Trials conducted in same day. Average time between trials 12-min | 3.54 km, hill 0.64 km 11% gradient | |
| Langford, 2017, USA [ | Non-randomized cross over | N = 17, 35% | Adults, part of e-bike sharing system | E-bike vs. CB vs. Walking | Trials conducted on separate days (minimum 24h rest) | 4.4 km, 1.6 km downhill (− 33.2 m), 1.8 km flat (− 0.3 m), 1.0 km uphill (+ 33.5 m). Self-selected pace |
| Louis, 2012, France [ | Randomized cross-over | Highly active adults (T) | E-bike NA vs. E-bike LA vs. E-bike HA | Trials conducted on same day. 5-min breaks between trials | Completed on indoor trainer. | |
| Meyer, 2014, Germany [ | Non-randomized cross over | Active adults, recreational cyclists | E-bike pedal assist vs. E-bike no assist | Trials conducted on separate days, 1-day apart. | 27 km track divided in 5 sections | |
| Simons, 2009, Netherlands [ | Non-randomized cross over | 42% inactive adults | E-bike NA vs. E-bike LA vs. E-bike HA | Trials conducted in same day. One-hour rest between trials. | 4.3 km, flat route, two stop and go section participants required to dismount and restart. Self-selected pace on pre-specified intensity | |
| Sperlich, 2012, Germany [ | Randomized cross over | Inactive adults | E-bike pedal assist vs. E-bike no assist | Trials conducted in same day. One-hour rest between trials. | 1.9 km × 5 = 9.5 km, 200 m uphill 1, 5.9%, 700 m downhill, 300 m uphill 2, 5.8%, 700 m flat. Self-selected pace and gear | |
| Theurel, 2011, France [ | Non-randomized cross over | Active postal workers | E-bike vs. CB | Trials conducted on same weekday, 1-month apart | Postal route, one group completed rides in residential neighbourhood, the other completed the ride in downtown location | |
| Theurel, 2012, France [ | Non-randomized cross over | Active adults | E-bike vs. CB | Trials separated by 1 week | 30-min of intermittent cycling on inside track alternating cycling of 10 sec duration and recovery of 20 sec. Aimed to complete 60 m in 10 sec (average speed = 21.6 km/hr) | |
| Longitudinal studies | ||||||
| Cooper, 2018, UK [ | Single group feasibility | Type 2 Diabetes | One group e-bike | Up to 5 months | E-bike training provided. Provision of e-bike for up to 5-months. Support for mechanical issues provided. No instruction on how or when to ride bike | |
| De Geus, 2013, Belgium [ | Non-randomized cross over | Inactive adults a | E-bike vs. Control | Control = 4 weeks | Instructed to ride e-bike at least three times per week to commute to and from work | |
| Hochsmann, 2017, Switzerland [ | Pilot randomized controlled trial | Inactive adults | E-bike vs. CB | 4 weeks | Instructed to use bike for active commute to work on at least 3-days per week, over 6 km. Self-selected pace | |
| Malnes, 2016, Norway [ | Single group pilot | Inactive adults | One group e-bike | Up to 8 months | 3 sites: 2 provided e-bikes for up to 8-months, 1 e-bike up to 3-months. | |
| Page, 2017, UK [ | Non-randomized two group | Unclear | E-bike commuting vs. passive commuting | Data reported mid-way into intervention – 2 months | No instructions on how to ride bike, full roadside assistance provided. | |
| Peterman, 2016, USA [ | Single group | Inactive adults | One group e-bike | 4 weeks | Instructed to ride e-bike at least 3 days per week for at least 40-min for commuting | |
T trained (engage in endurance sport at least 4 times per week), UT untrained (moderately active but less than 4× per week), Inactive <150 min/week of moderate to vigorous physical activity, Active ≥150 min/week of moderate to vigorous physical activity a report as sedentary but do not specifically measure moderate to vigorous physical activity, F female, M male, NA no assistance, LA low assistance, HA high assistance, CB conventional bike
Physical activity intensity outcomes of interest measured during rides*
| Study | Outcomes | Results; mean (SD) | ||||
|---|---|---|---|---|---|---|
| E-bike | Comparison 1 | Comparison 2 | Comparison 3 | Significance testing, | ||
| Bernsten, 2017 [ |
| E-bike | CB | |||
| Percentage VO2max | 51 (27) | 58 (28) | NC | |||
| Measured METs | 8.5 (3.1) | 10.9 (2.7) | NC | |||
| Estimated METs | 6.9 (2.1) | 8.4 (1.8) | NC | |||
| Cooper, 2018 [ | E-bike | Walking | ||||
| Mean HR | 125.2 (18.1) | 107.6 (15.8) | NC | |||
| Men | 121.2 (17.2) | 103.2 (14.1) | NC | |||
| Women | 132.6 (18.9) | 116.5 (16.9) | NC | |||
| Percentage HR max | 74.7 | 64.3 | NC | |||
| Gojanovic, 2011 [ | E-bike HA | E-bike LA | CB | Walking | ||
| Mean absolute VO2peak | 1.50 (.038) | 1.79 (0.46) | 2.00 (0.44) | 1.6 (0.34) | < 0.001 overall, <.05, all comparisons except HA vs. Walk (>.05) | |
| Percentage VO2peak | 54.9 (11) | 65.7 (8.1) | 72.8 (6.4) | 59 (9.1) | < 0.001 overall, <.05, all comparisons except HA vs. Walk (>.05) | |
| Mean estimated METs | 6.1 (1.4) | 7.3 (1.0) | 8.2 (1.3) | 6.5 (0.8) | < 0.001 overall, <.05, all comparisons except HA vs. Walk (>.05) | |
| Mean HR | 138.4 (18) | 149 (17.7) | 157.0 (11.2) | 132.7 (17.4) | < 0.001 overall, <.05, all comparisons except HA vs. Walk (>.05) | |
| Percentage HR max | 74.5 (8.7) | 80.3 (8.7) | 84.6 (5.2) | 71.5 (9.2) | < 0.001 overall, <.05, all comparisons except HA vs. Walk (>.05) | |
| Hansen, 2017 [ | E-bike HA | E-Bike LA | CB | |||
| Mean absolute VO2 | 1.72 (0.54) | 1.89 (0.62) | 1.85 (0.52) | .02 overall, .04 LA vs. HA, > .05 CB vs. LA, CB vs. HA | ||
| Percentage VO2peak | 68 (7.1) | 74 (6.2) | 73 (4.6) | .01 overall, .03 LA vs. HA, > .05 CB vs. LA, CB vs. HA | ||
| Mean estimated METs | 6 (1.8) | 6.6 (2) | 6.4 (1.6) | .02 overall; .027 HA vs. LA; >.05, CB vs LA, CB vs. HA | ||
| Hochsmann, 2017 [ |
| E-bike | CB | |||
| Percentage HR max+ | 74.9 (67.4, 82.8) | 73.3 (67.7, 78.2) | NC | |||
| Langford, 2017 [ | E-bike | CB | Walking | |||
| Mean relative VO2 | 16.95 (5.17) | 19.32 (5.47) | 15.12 (5.35) | NC | ||
| Mean relative EE per minute | 0.08 (0.03) | 0.10 (0.02) | 0.07 (0.03) | NC | ||
| Mean estimated METs | 5.1 | 5.8 | 4.5 | NC | ||
| Mean HR | 121.35 (17.04) | 127.45 (18.17) | 115.25 (14.41) | NC | ||
| Mean power output | 63.28 (22.89) | 73.13 (35.79) | NA | NC | ||
| La Salle, 2017 [ | E-bike | CB | ||||
| Mean absolute VO2 | 2.3 (0.1) | 2.5 (0.1) | .45 | |||
| Percentage VO2max | 66.4 (2.6) | 68 (2.8) | NR | |||
| Mean estimated METs | 8.3 (0.5) | 8.5 (0.6) | .65 | |||
| Mean HR | 147 (5) | 149 (5) | .064 | |||
| Percentage HR max | 79.1 (2.4) | 80.4 (2.6) | NR | |||
| Mean power output | 115 (11) | 128 (11) | .38 | |||
| Louis, 2012 [ |
| E-bike HA | E-bike LA | E-bike NA | ||
| Mean relative VO2 | 14.7 (2.0) | 19.5 (2.4) | 22.9 (2.2) | < .05, all comparisons | ||
| Mean estimated METs | 4.2 (0.6) | 5.6 (0.7) | 6.5 (0.6) | < .05, all comparisons | ||
| Mean absolute EE per minute | 5.1 (0.8) | 7.6 (0.8) | 7.8 (0.5) | < .05, all comparisons | ||
| Mean HR | 77.7 (11) | 89.4 (10.2) | 92.8 (11.6) | < .05, all comparisons | ||
| Mean power output | 47.3 (9.1) | 83.6 (4.0) | 104.2 (4.2) | < .05, all comparisons | ||
|
| E-bike HA | E-bike LA | E-bike NA | |||
| Mean relative VO2 | 15.0 (2.0) | 21.7 (4.2) | 23.4 (3.6) | < .05, all comparisons | ||
| Mean estimated METs | 4.3(0.6) | 6.2 (1.2) | 6.7 (1.0) | < .05, all comparisons | ||
| Mean absolute EE per minute | 4.9 (0.8) | 6.7 (0.8) | 7.5 (0.9) | < .05, all comparisons | ||
| Mean HR | 96.8 (16.8) | 116.8 (21.7) | 116.7 (16.2) | < .05, all comparisons | ||
| Mean power output | 40.0 (7.1) | 79.8 (4.8) | 99.9 (6.9) | < .05, all comparisons | ||
| Meyer 2014 [ | E-bike | E-bike NA | ||||
| Mean HR | 94.71 | 131.31 | NC | |||
| Peterman, 2016 [ | E-bike | |||||
| Mean estimate METs | 4.9 (1.2 | |||||
| Mean absolute EE per minute | 6.5 (1.9) | |||||
| Percentage HR max | 72.1 (5.4) | |||||
| Simons, 2009 [ | E-bike HA | E-bike LA | E-bike NA | |||
| Mean estimated METs | 5.2 (1.4) | 5.7 (1.2) | 6.1 (1.6) | <.05 HA and NA, >.05 HA vs. LA, LA vs. NA | ||
| Mean HR | 112.4 (22.9) | 116.2 (22.4) | 123.8 (23.2) | <.05 NA vs. HA; NA vs. LA, >.05 HA vs. LA | ||
| Percentage HR max | 6 7.1 (14.1) | 69.3 (13.5) | 73.9 (14.5) | <.05 NA vs. HA; NA vs. LA, >.05 HA vs. LA | ||
| Mean absolute power | 94.2 (29.2) | 101.8 (24.8) | 118.2 (30.9) | <.05 All comparisons | ||
| Sperlich, 2012 [ | E-bike | CB | ||||
| Mean relative VO2 | 18 (3.8) | 25.5 (4.8) | <.05, ES = 1.73 | |||
| Mean absolute VO2 | 1.33 (0.35) | 1.77 (0.43) | < .05, ES = 1.12 | |||
| Mean estimated METs | 5.2 (1.7) | 7.1 (1.4) | <.05, ES = 1.22 | |||
| Mean HR | 105 (20) | 133 (19) | <.05, ES = 1.53 | |||
| Mean absolute power | 363 (23) | 415 (28) | <.05, ES = 2.02 | |||
| Theurel, 2011 [ | E-bike | CB | ||||
| Mean absolute EE per minute | 5.6 (1.3) | 5.9 (1.8) | NR | |||
| Mean HR | NR | NR | .02, 3% lower with e-bike | |||
| Theurel, 2012 [ | E-bike | CB | ||||
| Mean relative VO2 | 29 (5) | 37 (5) | < .001 | |||
| Mean HR | 136 (23) | 167 (17) | <.001 | |||
*Given the difference in the cycle routes conducted mean values or percentage of maximum for outcomes related to physical activity intensity are reported (e.g., Mean VO2peak, mean heart rate, mean energy expenditure). For additional physical activity related outcomes reported in the studies see Additional file 4
+reported for only a subsample of the group (n = 5 e-bikes, n = 4 conventional bike)
EE energy expenditure, HR heart rate, METs metabolic equivalent, VO2 volume of oxygen, VO2 oxygen intake value; VO2max highest oxygen intake value attainable for an individual, VO2peak the highest oxygen intake value obtained on a specific test, CB conventional bike, HA high assistance, LA low assistance, NA no assistance
ES effect size measured as Cohen’s d, NC not conducted, NR not reported
Relative VO, VO and VO measured as ml/min/kg; Absolute VO, VO and VO measured in l/min; Mean absolute energy expenditure measured in kcal/min; Mean relative energy expenditure measured in kcal/kg/min; Mean heart rate measured in beats per minute (bpm); Mean power output measured in Watts, Estimated METs measured using assumption that resting energy expenditure (i.e.,1 MET) = 3.5 ml/kg/min; Measured METs measured through assessed individual resting energy expenditure
aResults are reported to total cycle routes. Studies separated results for different route topography. See Additional file 3 for details on different cycling topography; b Participants completed same activity at three different speeds, self-selected speed reported; c Total sample analyses not conducted, see Additional file 3 for analyses between ride segments
Results of longitudinal intervention studies
| Study | Outcomes | Results, mean, SD ( | ||||
|---|---|---|---|---|---|---|
| Intervention | Control | Significance, | ||||
| Pre | Post | Pre | Post | |||
| E-bike | ||||||
| Cooper, 2018 [ | Max absolute power | 157.5 (55.7) | 174.3 (70.8) | NC | ||
| Men | 182.1 (51.5) | 206.2 (64.9) | NC | |||
| Women | 118.9 (38.9) | 124.3 (49.0) | NC | |||
| E-bike | NE |
| ||||
| De Geus, 2013 [ | Absolute VO2peak | |||||
| Men | 2.56 (0.35) | 2.61 (0.38) | 2.62 (0.46) | 2.56 (0.35) | >.0.025 E-bike, NE | |
| Women | 1.94 (0.37) | 2.07 (0.41) | 1.91 (0.35) | 1.94 (0.37) | >.0.025 E-bike, NE | |
| Relative VO2peak | ||||||
| Men | 30.2 (4.3) | 30.7 (5.6) | 30.8 (4.9) | 30.2 (4.3) | >.0.025 E-bike, NE | |
| Women | 30.0 (6.0) | 32.3 (6.5) | 29.4 (5.1) | 30.0 (6.0) | >.0.025 E-bike, NE | |
| Absolute max power | ||||||
| Men | 169.5 (19.9) | 192.1 (28.7) | 173.8 (27.1) | 169.5 (19.9) | <.0.025 E-bike, >.0.025 NE | |
| Women | 130.9 (21.6) | 145.9 (24.8) | 131.1 (21.7) | 130.9 (21.6) | <.0.025 E-bike, >.0.025 NE | |
| Relative max power | ||||||
| Men | 2.00 (0.28) | 2.30 (0.40) | 2.05 (0.35) | 2.00 (0.28) | <.0.025 E-bike, >.0.025 NE | |
| Women | 2.03 (0.41) | 2.30 (0.55) | 2.04 (0.43) | 2.03 (0.41) | <.0.025 E-bike, >.0.025 NE | |
| E-bike | CB | |||||
| Hochsmann, 2017 [ | Relative VO2peak | 35.7 (5.8) | 39.3 (8.3) | 36.4 (7.3) | 38.6 (6.2) | 0.327, 1.4 (− 1.4–4.1)+ |
| Relative power output | 2.9 (0.6) | 3.2 (0.6) | 3 (0.5) | 3.3 (0.5) | 0.995, 0.0 (− 0.1–0.1)+ | |
| Resting HR | 64.7 (6.5) | 65.1 (7.6) | 68.8 (8.8) | 65.5 (10.6) | 0.505, 2.0 (−4.2–8.2) + | |
| HR at 100 W max text | 113.4 (9.2) | 111.5 (7.7) | 113.4 (15.9) | 109.2 (14.2) | 0.219, 2.4 (− 1.5–6.2) + | |
| SBP at rest | 125.9 (13.8) | 124.1 (11.3) | 127.3 (10.6) | 123.1 (12.4) | 0.538, 2.0 (−4.5–8.5) + | |
| DBP at rest | 82.4 (8.5) | 82.1 (8.2) | 87.7 (8) | 84.5 (8.8) | 0.625, 1.2 (−3.9–6.3) + | |
| SBP @ 100 W | 174.1 (22.9) | 160.3 (21.2) | 160.8 (20) | 150.4 (18.5) | 0.93, −0.4 (−9.4–8.7) + | |
| DBP @ 100 W | 86.2 (8.3) | 81.9 (6.5) | 88 (7.1) | 84 (8.1) | 0.709, −1.1 (−7.5–5.2) + | |
| E-bike | ||||||
| Malnes, 2016 [ | Relative VO2peak | 34.1 | 36.5 | <.001 | ||
| Relative VO2peak, % gain | 7.7 | |||||
| High Fitness | 1.5 (−5.6, 8.6) | 0.626 | ||||
| Low Fitness | 9.6 | <.05 | ||||
| Peak HR | 181 | 180 | 0.429 | |||
| E-bike commute | Passive commute | |||||
| Page, 2017 [ | QOL (baseline and week 8) | 38.00 (3.86) | 39.67 (4.47) | 29.63 (6.57) | 35.71 (5.59) | >.05 E-bike, Passive commute |
| OQL (week 4) | 38.84 (4.16) | 32.67 (6.08) | <.01, ES = 0.28 | |||
| E-bike | ||||||
| Peterman, 2016 [ | Absolute VO2max | 2.21 (0.48) | 2.39 (0.52) | <.05 | ||
| MVPA | 28.1 (17.5) | 29.0 (20.2) | >.05 | |||
| MVPA10+ | 11.7 (14.3) | 13.0 (15.2) | >.05 | |||
| Absolute max power | 165.1 (37.1) | 189.3 (38.3) | <.05 | |||
| Fasting glucose | 4.99 (0.52) | 5.02 (0.47) | >.05 | |||
| 2 h post plasma glucose | 5.53 (1.18) | 5.03 (0.91) | <.05 | |||
| HOMA | 2.46 (0.95) | 2.55 (0.82) | >.05 | |||
| Total cholesterol | 3.90 (0.87) | 3.92 (0.79) | >.05 | |||
| LDL | 2.33 (0.8) | 2.34 (0.71) | >.05 | |||
| HDL | 1.21 (0.24) | 1.18 (0.22) | >.05 | |||
| Triglycerides | 0.95 (0.42) | 0.91 (0.27) | >.05 | |||
| MAP | 84.6 (10.5) | 83.2 (9.4) | >.05 | |||
| SBP | 110.0 (12.4) | 109.1 (10.9) | >.05 | |||
| DBP | 67.7 (8.8) | 67.0 (8.0) | >.05 | |||
+difference between groups, 95% CI, ES = effect size
Distance (total and weekly) measured in kilometres; Duration (total and weekly) measured in minutes
NE no activity, CB conventional bike
SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial blood pressure, QOL quality of life, LDL low density lipo-protein, HDL high density lipo-protein, HOMA measure of insulin sensitivity using homeostatic model assessment, MVPA moderate to vigorous physical activity, MVPA10+ moderate to vigorous physical activity of bout of 10-min or greater, W watts
VO2max = highest oxygen value attainable for an individual, VO2peak = the highest oxygen intake value obtained on a specific test
Relative VO and VO measured as ml/min/kg; Absolute VO and VO measured in l/min Mean energy expenditure measured in kcal/min; Mean heart rate or peak heart rate measured in beats per minute (bpm); Mean absolute max power measured in Watts, Mean relative power measured in watts/kg; glucose, cholesterol, LDL, HDL, Triglycerides measured in mmol/L; blood pressure measured in millimeter of mercury (mmHg), MVPA and MVPA10+ measured in minutes per day
Quality assessment of included studies according to the Effective Public Health Practice Project tool
| Study | Component rating | Global ratinga | |||||
|---|---|---|---|---|---|---|---|
| Selection Bias | Design | Confounders | Blinding | Methods | Drop-outs | ||
| Acute studies | |||||||
| Bernsten [ | Weak | Strong | Strong | Weak | Strong | Strong | Moderate |
| Gojanovic [ | Weak | Moderate | Strong | Weak | Strong | Strong | Moderate |
| Hansen [ | Moderate | Strong | Strong | Weak | Strong | Strong | Moderate |
| Langford [ | Weak | Moderate | Strong | Weak | Strong | Moderate | Moderate |
| La Salle [ | Weak | Strong | Strong | Weak | Strong | Strong | Moderate |
| Louis [ | Weak | Strong | Strong | Weak | Strong | Weak | Weak |
| Meyer [ | Weak | Weak | Strong | Weak | Strong | Weak | Weak |
| Simons [ | Weak | Moderate | Strong | Weak | Strong | Strong | Moderate |
| Sperlich | Weak | Strong | Strong | Weak | Strong | Weak | Weak |
| Theurel, 2011 [ | Weak | Weak | Strong | Weak | Strong | Weak | Weak |
| Theurel, 2012 [ | Weak | Weak | Strong | Weak | Strong | Weak | Weak |
| Longitudinal studies | |||||||
| Cooper [ | Moderate | Moderate | Strong | Weak | Strong | Moderate | Moderate |
| De Geus [ | Weak | Moderate | Strong | Weak | Strong | Moderate | Moderate |
| Hochsmann [ | Moderate | Strong | Strong | Weak | Strong | Strong | Strong |
| Malnes [ | Weak | Moderate | Strong | Weak | Strong | Strong | Moderate |
| Page [ | Moderate | Weak | Weak | Weak | Strong | Weak | Weak |
| Peterman [ | Weak | Moderate | Strong | Weak | Strong | Moderate | Moderate |
aStrong = no weak component rating; moderate = one weak component rating; weak = two or more weak component ratings
Note: blinding was not included in the overall global rating calculation